The objective of this study is to describe the clinical outcomes of patients treated for cervical pregnancy with or without methotrexate (MTX) and to evaluate the effects of MTX in the treatment of cervical pregnancy. Between January 1993 and February 2000, 31 patients were diagnosed with cervical pregnancy. Twenty-two patients were treated with MTX chemotherapy and nine patients were treated with surgical procedures without MTX treatment. In the non-MTX treatment group, three patients underwent total abdominal hysterectomy, five required adjuvant procedures to control the bleeding during dilatation and curettage (D&C) and only one patient was treated with a simple D&C. In the MTX treatment group, fourteen (63.6%) patients were treated with only MTX and eight (36.4%) cases underwent concomitant procedures (simple curettage, curettage and Foley catheter tamponade, cer-vical cerclage, ligation of the descending branches of uterine arteries, or ligation of hypogastric arteries). The uterus was preserved in all cases and three women delivered healthy babies in their subsequent pregnancy. In conclusion, early diagnosis, appropriate MTX regimen in combination of necessary adjuvant conservative procedures could contribute to successful treatment with preservation of the uterus and future reproductive ability.
Abortifacient Agents, Nonsteroidal/administration & dosage ; Comparative Study ; Dilatation and Curettage/*statistics & numerical data ; Female ; Humans ; Incidence ; Korea/epidemiology ; Methotrexate/*administration & dosage ; Pregnancy ; Pregnancy, Ectopic/*drug therapy/epidemiology/*surgery ; Retrospective Studies ; Risk Assessment/*methods ; Risk Factors ; Treatment Outcome

Thirty-two adult female ASA I patients (American Society of Anesthesiologists' grading) undergoing voluntary termination of pregnancy (VTP) under general anaesthesia were randomly divided into three groups. Patients received 0.6 mg/kg pentazocine intravenously five minutes prior to induction of anaesthesia along with either isotonic saline, or promethazine 0.5 mg/kg or metoclopramide 0.2 mg/kg. Anaesthesia was induced with intravenous thiopentone and maintained with nitrous oxide in oxygen and boluses of thiopentone. Vomiting and sedation were scored at the end of anaesthesia, one hour later and at the time of discharge. The mean vomiting score was comparable in the three groups. Though the mean dose of thiopentone used was significantly less in the promethazine group, the sedation scores and the duration of stay in the clinic were comparable in all the groups. It is concluded that promethazine and metoclopramide in the doses used are ineffective as antiemetic agents in outpatient gynaecological patients.
Abortion, Induced ; methods ; Adult ; Ambulatory Surgical Procedures ; methods ; Analysis of Variance ; Anesthesia, General ; adverse effects ; Chi-Square Distribution ; Dilatation and Curettage ; methods ; Female ; Humans ; Metoclopramide ; administration & dosage ; therapeutic use ; Pregnancy ; Promethazine ; administration & dosage ; therapeutic use ; Statistics, Nonparametric ; Vomiting ; etiology ; prevention & control